SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+15.17%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$329M
AUM Growth
+$329M
(+17%)
Cap. Flow
+$21.5M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
47.62%
Holding
92
New
27
Increased
14
Reduced
15
Closed
20
Top Buys
| 1 |
Merck
MRK
|
$15.4M |
| 2 |
Gilead Sciences
GILD
|
$12.1M |
| 3 |
GSK
GSK
|
$9.62M |
| 4 |
Sanofi
SNY
|
$8.58M |
| 5 |
Medtronic
MDT
|
$7.52M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$18.6M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$9.91M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$7.52M |
| 4 |
Avantor
AVTR
|
$6.99M |
| 5 |
InMode
INMD
|
$5.79M |
Sector Composition
| 1 | Healthcare | 92.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
1
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $19.4M | 4.63% | 185,757 +6,043 | +3% | +$632K |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $18.5M | 4.41% | 96,931 -3,698 | -4% | -$707K |
|
3
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $17M | 4.06% | 946,761 +341,976 | +57% | +$6.16M |
|
|
4
Medtronic
MDT
$119B
| $16.7M | 3.97% | 147,022 +66,320 | +82% | +$7.52M |
|
5
HCA Healthcare
HCA
$94.5B
| $16.2M | 3.86% | 109,599 -25,000 | -19% | -$3.7M |
|
|
6
Merck
MRK
$210B
| $15.4M | 3.68% | +169,755 | New | +$15.4M |
|
7
Pfizer
PFE
$141B
| $14.9M | 3.55% | 380,874 +94,424 | +33% | +$3.7M |
|
|
WCG
8
DELISTED
Wellcare Health Plans, Inc.
WCG
| $14.8M | 3.53% | 44,935 -5,500 | -11% | -$1.82M |
|
|
9
Gilead Sciences
GILD
$140B
| $12.1M | 2.88% | +186,000 | New | +$12.1M |
|
10
United Therapeutics
UTHR
$13.8B
| $11.7M | 2.78% | 132,664 +45,000 | +51% | +$3.96M |
|
11
Molina Healthcare
MOH
$9.8B
| $9.94M | 2.37% | 73,236 +40,746 | +125% | +$5.53M |
|
|
12
GSK
GSK
$79.9B
| $9.62M | 2.29% | +204,705 | New | +$9.62M |
|
13
McKesson
MCK
$85.4B
| $9.47M | 2.25% | 68,439 +5,249 | +8% | +$726K |
|
14
Cencora
COR
$56.5B
| $9.46M | 2.25% | 111,249 +8,146 | +8% | +$693K |
|
15
Regeneron Pharmaceuticals
REGN
$61.5B
| $9.3M | 2.22% | 24,776 | – | – |
|
16
Elevance Health
ELV
$71.8B
| $9.28M | 2.21% | 30,739 +3,454 | +13% | +$1.04M |
|
|
17
Sanofi
SNY
$121B
| $8.58M | 2.04% | +170,977 | New | +$8.58M |
|
|
BEAT
18
DELISTED
BioTelemetry, Inc.
BEAT
| $7.41M | 1.76% | 160,015 -31,025 | -16% | -$1.44M |
|
19
MEI Pharma
MEIP
$160M
| $5.95M | 1.42% | 2,398,852 +2,140,000 | +827% | +$5.31M |
|
20
Viking Therapeutics
VKTX
$3.04B
| $5.87M | 1.4% | 731,453 -23,306 | -3% | -$187K |
|
21
Immunovant
IMVT
$2.56B
| $5.48M | 1.31% | +615,400 | New | +$5.48M |
|
22
Merit Medical Systems
MMSI
$5.36B
| $4.68M | 1.12% | +150,000 | New | +$4.68M |
|
23
Ardelyx
ARDX
$1.53B
| $4.67M | 1.11% | +621,534 | New | +$4.67M |
|
|
HRC
24
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $4.56M | 1.09% | 40,182 | – | – |
|
|
25
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4.22M | 1% | 36,632 -86,021 | -70% | -$9.91M |
|